Gene editing has arrived. Of the various forms of the technology, CRISPR-Cas9 is the easiest to use, and it’s already showing up in summer camps and school science labs near you. That would be middle schools.
When everyone can edit an... Read more »
In a surprising statement late today from the White House, President Donald Trump unilaterally prohibited Broadcom’s proposed takeover of Qualcomm (NASDAQ: QCOM), the world’s biggest maker of chips for smartphones.
Citing a recommendation from a national security panel and other... Read more »
Orexigen Therapeutics has filed for bankruptcy to sell its weight loss pill to the highest bidder. The news follows years of ups and downs for Orexigen, which piled up debt as it struggled to successfully market its obesity drug, known as... Read more »
For 20 years, Deborah Long (pictured) has been relying on powerful drugs to keep her multiple sclerosis in check. Her out-of-pocket costs were pretty reasonable until two years ago, she says, when she had to switch insurance companies. Her new insurer... Read more »
After learning that Proper Media, a San Diego specialist in programmatic digital advertising had acquired Spoutable, it took a couple weeks to catch up with Spoutable CEO Jon Belmonte and ask: What happened to Cursive Labs?
Spoutable began more than... Read more »
Regeneron Pharmaceuticals and partner Sanofi report new data this morning from a large, highly-anticipated trial suggesting that their drug alirocumab (Praluent) may reduce the risk of death for people with high cholesterol who have recently suffered heart attacks or strokes and are... Read more »
[Updated 3/13/18 1:07 pm. See below.] If a shopper interacts with technology in a typical grocery store, it’s usually at the very end—as they are paying for their items.
That could be about to change, though. “Scanning loyalty cards... Read more »
Trump administration health officials were out on the stump this week, talking tough about drug prices and healthcare value, encouraging the private sector to take the lead but letting everyone know the federal government is willing to push.
In the debate... Read more »
Xconomy will explore the confluence of “big biology” with “big data” at our half-day forum on April 26.
Just as the computing industry opened the way to technologies that enabled people to manage and analyze information in unprecedented ways, a... Read more »